Kuros Biosciences AG (ETR:YTSN)

Market Cap	1.18B
Revenue (ttm)	80.53M
Net Income (ttm)	-4.57M
Shares Out	n/a
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	407.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	60
Open	28.86
Previous Close	28.86
Day's Range	28.86 - 29.98
52-Week Range	1.65 - 32.28
Beta	n/a
RSI	52.03
Earnings Date	Aug 14, 2025

About Blueprint Medicines

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Employees: 122
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: YTSN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.